Jiezhong Chen, PhD

School of Biomedical Sciences and Australian Institute for Bioengineering and Nanotechnology, The University of Queensland, St Lucia, QLD, Australia

Dr. Chen has studied multiple signalling pathways in several diseases for many years. His main research interest is to elucidate the critical role of PI3K/Akt/mTOR pathway in obesity-associated cancer and HPV-caused cancer. He has also studied targeted therapy using small molecule inhibitors and nano-delivery of anti-cancer drugs for the treatment of colon cancer and melanoma. Recently, Dr. Chen has extended his signalling pathway studies into diabetes research, particularly beta-cell proliferation and apoptosis.

Dr. Chen has had more than 100 peer reviewed publications in various journals including Lancet, Nat Rev Gastroenterol Hepatol, Hepatology, FEMs Microbiol Rev, Hepatology, Cancer Lett, Cell Death Dis, Biomaterials, Tissue Engineering, Obesity Rev, Mol Nutr Food Res and Rev Med Virol.